PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.\', \'Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: hwillers@mgh.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0167-8140(21)09005-810.1016/j.radonc.2021.11.012
?:doi
?:hasPublicationType
?:journal
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
is ?:pmid of
?:pmid
?:pmid
  • 34838892
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34838892>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34838892>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all